|
Druker B J, Talpaz M, Resta D J, et a1. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia [J]. New England Journal of Medicine, 2001, (14):1031.doi: 10.1056/NEJM200104053441401.
|
|
GOLDMAN J M, Melo J V. Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia [J]. New England Journal of Medicine, 2001, (14):1084.doi: 10.1056/NEJM200104053441409.
|
|
Druker B J, Sawyers C L, Kantarjian H. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome [J]. New England Journal of Medicine, 2001, (14):1038.doi: 10.1056/NEJM200104053441402.
|
|
Talpaz M, Silver R T, Druker B J. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid 1eukemia:results of a phase2 study [J]. Blood, 2002.1928.doi: 10.1182/blood.V99.6.1928.
|
|
Sawyers C L, Hochhaus A, Feldman E. Imatinib mesylate induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis:results of a phase Ⅱ study [J]. Blood, 2002.3530.doi: 10.1182/blood.V99.10.3530.
|
|
Ottmann O G, Druker B J, Sawyers C L. A phase Ⅱ study of imatinib Mesylate(Gleevec) in patients with relapsed or refractory Philadelphia chromosome positive acute lymphoid leukemia [J]. Blood, 2002.1965.doi: 10.1182/blood-2001-12-0181.
|
|
Sacchi S, Kantarjian H M, O'Brien S. 3.0.CO;2-A.aspx">Chronic myelogenous leukemia in nonlymphoid blastic phase:analysis of the results of first salvage therapy with three different treatment approaches for 162 patients [J]. Cancer, 1999.2632.doi: 10.1002/(SICI)1097-0142(19991215)86:12<2632::AID-CNCR7>3.0.CO;2-A.
|
|
Walters R S, Kantarjian H M, Keating M J. Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron [J]. CANCER, 1987.1708.doi: 10.1002/1097-0142(19871015)60:8<1708::AID-CNCR2820600803>3.0.CO;2-1.
|
|
Copelan E A, Mcguire E A. The biology and treatment of acute 1ymphoblastic leukemia in adults [J]. Blood, 1995.1151.
|
|
C1ift R A, Storb R. Marrow transplantation for CML:the Seattle experience [J]. Bone Marrow Transplantation, 1996, (zk3):S1.
|
下载:
苏公网安备 32100302010246号
